Articles
Media
All VideosCase Based Roundtable SeriesEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsViewpoints
Publications
Digital EditionSupplements And Featured Publications
Conferences
Conference Listing
More
CME/CE
Resources
SponsoredZEISS Clinical CasesZeiss Cataract InsightsZeiss Cataract DigitalizationEnhancing the Patient JourneyEYLEA 8mg for nAMD and DME TreatmentBetween the Lines

Subscribe

  • Articles
  • Media
  • Publications
  • Conferences
  • CME/CE
  • Resources
  • Subscribe
  • AMD
  • Cataract & Refractive
  • Cornea
  • Gene Therapy
  • Glaucoma
  • Inflammation & Infection
  • Paediatrics
  • Retina
Spotlight -
ZEISS Clinical Cases|
Heidelberg Engineering: Enhancing the Patient Journey
Advertisement

Shu-I Yeh, MD, PhD

Advertisement

Articles by Shu-I Yeh, MD, PhD

©WavebreakMediaMioro / stock.adobe.com

New strategies for severe ocular surface and corneal disease

ByShu-I Yeh, MD, PhD
March 29th 2023

Regenerative technologies are providing an influx of options.

Advertisement

Latest Updated Articles

  • ©WavebreakMediaMioro / stock.adobe.com
    New strategies for severe ocular surface and corneal disease

    Published: March 29th 2023 | Updated:



Advertisement
Advertisement

Trending on Ophthalmology Times Europe

1

Macular laser picks up speed: The technology accelerating retinal therapies

2

FLORetina 2025: Long-term follow-up in paediatric gene therapy

3

FLORetina 2025: EU-ROP Registry bridges borders for real-world insight

4

FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage

5

FLORetina 2025: New horizons in research and risk management for ROP

  • Advertise
  • About Us
  • Editorial Info
  • Editorial Board
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us